Understanding how a protein called Rap1 affects blood clotting and platelet function
The Role of the small GTPase Rap1 in Platelet-Coagulation Interplay
This study is looking at how a tiny protein called Rap1 helps platelets, the cells that stop bleeding, stick together and work properly, which could help us understand and treat bleeding disorders and blood clots better.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10904771 on NIH RePORTER |
What this research studies
This research investigates the role of the small GTPase Rap1 in the activation of platelets, which are crucial for stopping bleeding after vascular injury. By examining how Rap1 influences platelet adhesion and aggregation, the study aims to uncover the mechanisms that regulate the exposure of phosphatidylserine, a lipid that plays a key role in blood coagulation. The research employs advanced imaging techniques to visualize these processes in real-time, providing insights into both normal and pathological platelet function. This could lead to better understanding and management of bleeding disorders and thrombotic diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with known bleeding disorders or thrombotic conditions.
Not a fit: Patients with stable platelet function and no history of bleeding or thrombotic disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for patients with bleeding disorders or those at risk of thrombosis.
How similar studies have performed: Previous research has shown that understanding platelet activation mechanisms can lead to significant advancements in treating coagulation disorders, indicating that this approach has potential for success.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Ballard, Abigail Rene — Univ of North Carolina Chapel Hill
- Study coordinator: Ballard, Abigail Rene
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.